Medicaid Bulletin

Effective with date of service Jan. 27, 2023, the Medicaid and NC Health Choice programs covers ublituximab-xiiy injection, for intravenous use (Briumvi)

Effective with date of service Jan. 23, 2023, the Medicaid and NC Health Choice programs cover pegfilgrastim-fpgk

Effective with date of service Jan. 20, 2023, the Medicaid and NC Health Choice programs cover fecal microbiota, live - jslm suspension, for rectal use (Rebyota).

Effective with date of service Jan. 30, 2023, the Medicaid and NC Health Choice programs cover bendamustine hydrochloride injection, for intravenous use (Baxter).

In compliance with federal requirements, beneficiary consent is required for all voluntary sterilizations.

Effective immediately, all providers must use the Electronic Visit Verification vendor of their choice for every home health visit.

Effective April 1, 2023, NC Medicaid covers ambulatory blood pressure monitoring. This helps confirm or exclude suspected hypertension.

Clarifies requirements related to Research Based-Behavioral Health Treatment and Specialized Consultative Services and New Taxonomy

Physician’s signature on the CMS 485 Plan of Care form

Providers are required to make adequate provision for return of any money incorrectly collected